For the quarter ending 2025-09-30, CNTX has $79,231,160 in assets. $6,056,994 in debts. $76,938,183 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 76,938,183 | 83,517,047 | ||
| Prepaid expenses and other current assets | 2,120,634 | 3,431,188 | ||
| Total current assets | 79,058,817 | 86,948,235 | ||
| Property and equipment, net | 33,721 | 37,787 | ||
| Operating lease right-of-use lease asset | 138,622 | 166,079 | ||
| Total assets | 79,231,160 | 87,152,101 | ||
| Accounts payable | 2,720,876 | 2,395,880 | ||
| Accrued expenses and other current liabilities | 3,195,918 | 2,044,580 | ||
| Operating lease liability - current | 118,980 | 114,985 | ||
| Total current liabilities | 6,035,774 | 4,555,445 | ||
| Operating lease liability - non-current | 21,220 | 52,334 | ||
| Total liabilities | 6,056,994 | 4,607,779 | ||
| Common stock, 0.001 par value 200,000,000 shares authorized at september30, 2025 and december31, 2024 91,879,177 and 89,704,194 shares issued and outstanding at september30, 2025 and december31, 2024, respectively | 91,879 | 89,704 | ||
| Additional paid-in capital | 190,959,989 | 190,639,083 | ||
| Accumulated deficit | -117,877,702 | -108,184,465 | ||
| Total stockholders' equity | 73,174,166 | 82,544,322 | ||
| Total liabilities and stockholders' equity | 79,231,160 | 87,152,101 | ||
Context Therapeutics Inc. (CNTX)
Context Therapeutics Inc. (CNTX)